Cognex Corp: Form 10-Q for the period ended Jul 4, 2021
Filed with the SEC on Aug 5, 2021 and accepted by EDGAR at Aug 5, 2021, 16:10 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-07-04. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-04-05 to 2021-07-04 | $269.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2021-01-01 to 2021-07-04 | $508.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-04-05 to 2021-07-04 | $68.4m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2021-01-01 to 2021-07-04 | $122.5m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2021-04-05 to 2021-07-04 | $200.7m | us-gaap:GrossProfit |
| Gross profit | 6 months2021-01-01 to 2021-07-04 | $385.7m | us-gaap:GrossProfit |
| Research and development | 3 months2021-04-05 to 2021-07-04 | $31.3m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2021-01-01 to 2021-07-04 | $65.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2021-04-05 to 2021-07-04 | $76.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2021-01-01 to 2021-07-04 | $149.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2021-04-05 to 2021-07-04 | $92.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2021-01-01 to 2021-07-04 | $171.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2021-04-05 to 2021-07-04 | $15.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2021-01-01 to 2021-07-04 | $24.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-04-05 to 2021-07-04 | $77.6m | us-gaap:NetIncomeLoss |
| Net income | 6 months2021-01-01 to 2021-07-04 | $147.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-04-05 to 2021-07-04 | $0.43 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2021-01-01 to 2021-07-04 | $0.82 | us-gaap:EarningsPerShareDiluted |
| Diluted shares (weighted) | 3 months2021-04-05 to 2021-07-04 | 179,991,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2021-01-01 to 2021-07-04 | 179,982,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2021-01-01 to 2021-07-04 | $194.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2021-01-01 to 2021-07-04 | $6.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2021-01-01 to 2021-07-04 | $21.2m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2021-01-01 to 2021-07-04 | $20.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-07-04 | $217.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-07-04 | $692.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-07-04 | $2.02bn | us-gaap:Assets |
| Current liabilities | At period end2021-07-04 | $204.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-07-04 | $595.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2021-07-04 | $1.43bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2021-07-04 | 176,707,164 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000851205-21-000020. Last ingested by Listed: Nov 10, 2026, 23:02 ET. Listed shows no prices and gives no investment advice.